COMMUNIQUÉS West-GlobeNewswire

Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s Syndrome
28/08/2019
MENLO PARK, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for a patent [...]
Diversicare's Common Stock Will be Traded on the OTCQX Following the Delisting From NASDAQ
28/08/2019
BRENTWOOD, Tenn., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) was notified by The Nasdaq Stock Market LLC ("Nasdaq") that the Nasdaq Hearings Panel denied the Company’s recent [...]
CB2 Insights Reports Second Quarter Fiscal 2019 Financial Results, Sees Positive Impact from New Acquisitions
28/08/2019
Revenue Increases 14% Over the Prior Quarter; 14% Improvement in Net Income/Loss Position TORONTO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB:CBIIF) (“ CB2 ” or the “ Company ”), a leading [...]
Alder BioPharmaceuticals® to Present at Two Upcoming September Investor Conferences
28/08/2019
BOTHELL, Wash., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Transparency notification – Gilead holds 22% of Galapagos shares
28/08/2019
Mechelen, Belgium; 28 August 2019; 22.01 CEST; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Gilead Sciences, Inc. Pursuant to Belgian transparency [...]
Reata Appoints Manmeet S. Soni as Chief Financial Officer; Jason D. Wilson to Assume New Role as EVP, Operations
28/08/2019
IRVING, Texas, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced the appointment of Manmeet S. Soni as Chief Financial Officer (CFO [...]
Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results
28/08/2019
– TransCon hGH moves towards Biologics License Application submission following completion of heiGHt and fliGHt Trials – – Global reach of endocrinology rare disease programs expands – – Conference call today at 4:30 p. [...]
Trevena Advances NDA Resubmission Activities for Oliceridine
28/08/2019
— Completed enrollment in healthy volunteer QT study, topline data expected in Q4 2019 — — Completed characterization of inactive metabolite — — Remains on track to resubmit NDA in Q1 2020 — CHESTERBROOK, Pa., Aug. 28, [...]
Adverum Biotechnologies to Present 24-Week Data from First Cohort of OPTIC Trial of ADVM-022 Intravitreal Injection Gene Therapy to Treat Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting in October
28/08/2019
Dr. Szilard Kiss to Present at the Late Breaking Developments Session During the Retina Subspecialty Day Program on October 11, 2019 MENLO PARK, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. ( [...]
Align Technology to Speak at an Upcoming Financial Conference
28/08/2019
SAN JOSE, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) today announced that the company is scheduled to speak at an upcoming financial conference. The presentation, as noted below, [...]
PROJECT HOPE PREPARES FOR AFTERMATH OF TROPICAL STORM DORIAN IN PUERTO RICO
28/08/2019
Project HOPE’s local team gears up to meet anticipated health needs Millwood, Virginia, Aug. 28, 2019 (GLOBE NEWSWIRE) -- The global health and humanitarian organization Project HOPE is actively monitoring Tropical [...]
Emerald Health Therapeutics annonce un financement de parts de débentures convertibles de 25 millions USD
28/08/2019
CE COMMUNIQUÉ DE PRESSE NE DOIT PAS ÊTRE DISTRIBUÉ AUX AGENCES DE PRESSE AMÉRICAINES ET NE DOIT PAS ÊTRE DIFFUSÉ AUX ÉTATS-UNIS VANCOUVER, Colombie-Britannique, 28 août 2019 (GLOBE NEWSWIRE) -- Emerald Health [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2019
28/08/2019
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2019 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]
Inventiva secures a new European patent strengthening and extending the protection of its lead product candidate lanifibranor
28/08/2019
Inventiva secures a new European patent strengthening and extending the protection of its lead product candidate lanifibranor The latest European patent granted by the European Patent Office protects the use of [...]
Inventiva enregistre un nouveau brevet européen renforçant et étendant la protection de son candidat médicament phare lanifibranor
28/08/2019
Inventiva enregistre un nouveau brevet européen renforçant et étendant la protection de son candidat médicament phare lanifibranor Le nouveau brevet européen délivré par l’Office Européen des Brevets protège l’ [...]
RAMSAY GENERALE DE SANTE : provisional annual results at the end of June 2019
28/08/2019
PRESS RELEASE Paris, 28 August 2019 Provisional annual results at the end of June 2019 Good results and solid perspectives Annual reported turnover up 51.7% to EUR 3,401.1 million. On a like-for-like basis, good growth [...]
RAMSAY GENERALE DE SANTE : Résultats annuels provisoires à fin juin 2019
28/08/2019
COMMUNIQUE DE PRESSE Paris, le 28 août 2019 Résultats annuels provisoires à fin juin 2019 De bons résultats et de solides perspectives Chiffre d’affaires annuel publié en hausse de 51,7% à 3 401,1 millions d’euros. A [...]
Axiom Real-Time Metrics Showcasing Fusion eClinical Suite at DeviceFest & Digital Heath Conference in Southern California
28/08/2019
TORONTO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is exhibiting today at Biocom’s annual DeviceFest and Digital Health Conference [...]
Corrected News Release - United Health Products Announces Completion of Human Trial Study
28/08/2019
HENDERSON, Nev., Aug. 28, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose that is patented through [...]

Pages